» Articles » PMID: 23649450

Complementary Therapies and Integrative Medicine in Lung Cancer: Diagnosis and Management of Lung Cancer, 3rd Ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2013 May 8
PMID 23649450
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Physicians are often asked about complementary therapies by patients with cancer, and data show that the interest in and use of these therapies among patients with cancer is common. Therefore, it is important to assess the current evidence base on the benefits and risks of complementary therapies (modalities not historically used in modern Western medicine).

Methods: A systematic literature review was carried out and recommendations were made according to the American College of Chest Physicians Evidence-Based Clinical Practice Guidelines development methodology.

Results: A large number of randomized controlled trials, systematic reviews, and meta-analyses, as well as a number of prospective cohort studies, met the predetermined inclusion criteria. These trials addressed many different issues pertaining to patients with lung cancer, such as symptoms of anxiety, mood disturbance, pain, quality of life, and treatment-related side effects. The available data cover a variety of interventions, including acupuncture, nutrition, mind-body therapies, exercise, and massage. The body of evidence supports a series of recommendations. An evidenced-based approach to modern cancer care should integrate complementary therapies with standard cancer therapies such as surgery, radiation, chemotherapy, and best supportive care measures.

Conclusions: Several complementary therapy modalities can be helpful in improving the overall care of patients with lung cancer.

Citing Articles

Research Hotspots and Trends in Acupuncture for Cancer:A bibliometric analysis from 2004 to 2024.

Ji Z, Niu H, He A, Li K, Jia J, Zhang M J Multidiscip Healthc. 2025; 18:531-547.

PMID: 39911755 PMC: 11794041. DOI: 10.2147/JMDH.S494138.


Erianin inhibits the progression of DDP-resistant lung adenocarcinoma by regulating the Wnt/β-catenin pathway and activating the caspase-3 for apoptosis in vitro and in vivo.

Tang L, Ruan Y, Wang B, Zhang M, Xue J, Wang T Hereditas. 2024; 161(1):48.

PMID: 39605083 PMC: 11600767. DOI: 10.1186/s41065-024-00351-x.


Quality appraisal of clinical practice guidelines addressing massage interventions using the AGREE II instrument.

Fan M, Liu A, Lu T, Zhou X, Tian C, Liu B Syst Rev. 2024; 13(1):83.

PMID: 38459534 PMC: 10921609. DOI: 10.1186/s13643-024-02503-6.


Characteristics and Challenges of Providing Acupuncture and Chinese Herbal Medicine in Oncology Treatment: Report of Survey Data and Experience of Five Unique Clinical Settings.

Veleber S, Cohen M, Weitzman M, Maimon Y, Adamo C, Siman J Integr Cancer Ther. 2024; 23:15347354241226640.

PMID: 38288552 PMC: 10826404. DOI: 10.1177/15347354241226640.


The Effects of Complementary Therapies on Patient-Reported Outcomes: An Overview of Recent Systematic Reviews in Oncology.

Mentink M, Verbeek D, Noordman J, Timmer-Bonte A, von Rosenstiel I, van Dulmen S Cancers (Basel). 2023; 15(18).

PMID: 37760483 PMC: 10526744. DOI: 10.3390/cancers15184513.